Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Inventory Average of $843.6 million for Q2 2026, down 2.16% on a QoQ basis from $862.2 million in Q1 2026, and down 1.0% year-over-year from $852.1 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Inventory Average for 18 years, with the latest figure at $843.6 million in Q2 2026.
- On a quarterly basis, Inventory Average fell 1.0% year-over-year to $843.6 million in Q2 2026; TTM through Jun 2026 was $843.6 million, a 1.0% decrease from a year earlier, with the FY2026 full-year figure at $824.0 million, up 3.32% from the prior year.
- Inventory Average was $843.6 million for Q2 2026 at Dr Reddys Laboratories, down from $862.2 million in the prior quarter.
- The five-year high for Inventory Average was $878.2 million in Q4 2025, with the low at $596.4 million in Q1 2023.
- Average Inventory Average over 5 years is $753.3 million, with a median of $770.7 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Inventory Average decreased 10.96% in 2023, then gained 29.06% in 2024.
- Over 5 years, Inventory Average stood at $608.0 million in 2022, then gained by 16.35% to $707.4 million in 2023, then climbed by 20.76% to $854.2 million in 2024, then gained by 2.81% to $878.2 million in 2025, then slipped by 3.95% to $843.6 million in 2026.
- The last three Inventory Average figures came in at $843.6 million (Q2 2026), $862.2 million (Q1 2026), and $878.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 3.20 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 3.93 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 843.60 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 659.79 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1.60 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 227.28 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 143.31 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 175.05 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 843.60 Mn |
| Mar 31, 2026 | 862.21 Mn |
| Dec 31, 2025 | 878.25 Mn |
| Sep 30, 2025 | 876.32 Mn |
| Jun 30, 2025 | 852.13 Mn |
| Mar 31, 2025 | 834.63 Mn |
| Dec 31, 2024 | 854.23 Mn |
| Sep 30, 2024 | 841.04 Mn |
| Jun 30, 2024 | 793.62 Mn |
| Mar 31, 2024 | 747.71 Mn |
| Dec 31, 2023 | 707.37 Mn |
| Sep 30, 2023 | 661.18 Mn |
| Jun 30, 2023 | 614.92 Mn |
| Mar 31, 2023 | 596.43 Mn |
| Dec 31, 2022 | 607.95 Mn |
| Sep 30, 2022 | 643.51 Mn |
| Jun 30, 2022 | 674.30 Mn |
| Mar 31, 2022 | 669.85 Mn |
| Dec 31, 2021 | 666.88 Mn |
| Sep 30, 2021 | 679.66 Mn |